SCHEMBL3616874

SCHEMBL3616874

CCCCOC(=O)N(C)C(C)O

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.47
ATM Q13315 1/20 0.44
HPGD P15428 3/20 0.41
TSHR P16473 2/20 0.41
CHRNB2 P17787 1/20 0.39
CHRNA4 P43681 1/20 0.39
HCAR2 Q8TDS4 1/20 0.39
NAAA Q02083 1/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
TDP1 Q9NUW8 1/20 0.38
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
MAPT P10636 2/20 0.37
KDM4E B2RXH2 1/20 0.37
MAPK1 P28482 1/20 0.37
MCL1 Q07820 1/20 0.37
EPHX1 P07099 1/20 0.36
DNM1 Q05193 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3059935 0.81 ALDH1A1 (0.44) ALDH1A1ATMHPGDTSHRCHRNB2
SCHEMBL31269529 0.81 ALDH1A1 (0.44) ALDH1A1ATMHPGDTSHRCHRNB2
SCHEMBL1759122 0.81 ALDH1A1 (0.44) ALDH1A1ATMHPGDTSHRCHRNB2
SCHEMBL31269561 0.81 ALDH1A1 (0.44) ALDH1A1ATMHPGDTSHRCHRNB2
SCHEMBL8382644 0.80 ALDH1A1 (0.42) ALDH1A1ATMHPGDTSHRCHRNB2
SCHEMBL22689397 0.80 ATM (0.44) ALDH1A1ATMHPGDTSHRCHRNB2
SCHEMBL8382643 0.80 ALDH1A1 (0.42) ALDH1A1ATMHPGDTSHRCHRNB2
SCHEMBL3434106 0.79 ALDH1A1 (0.41) ALDH1A1ATMHPGDTSHRCHRNB2
SCHEMBL28494423 0.79 ALDH1A1 (0.41) ALDH1A1ATMHPGDTSHRCHRNB2
SCHEMBL1868925 0.78 ALDH1A1 (0.48) ALDH1A1ATMHPGDTSHRHCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8314247-B2 Hydrazone derivative MITSUBISHI TANABE PHARMA CORPORATION (JP) 2012-11-20 US disclosed
US-20100099662-A1 HYDRAZONE DERIVATIVE MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-04-22 US disclosed
EP-2105435-A1 HYDRAZONE DERIVATIVE Mitsubishi Tanabe Pharma Corporation (JP) 2009-09-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100099662-A1 HYDRAZONE DERIVATIVE GCK, GCKR, HK1 ALDH1A1 1260/4885ATM 1159/4885HPGD 1353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.